Delivery Order SPE2DB20D3103-SPE2DB25FL6E0
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,709,355 units of the drug Letrozole 2.5 mg tablet in 90-count packages. The contract has a ceiling value of $2,163.36 and an ultimate completion date of December 13, 2024. It is a delivery order contract with a firm fixed price. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
The federal contract award provides a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,566,976,311 units of the medication Letrozole 2.5 mg tablets to the Defense Logistics Agency (DLA). The $1,081.74 firm fixed price award has a completion date of January 21, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,357.58 firm fixed-price delivery order is for the supply of 90-count tablets of the drug Letrozole 2.5 mg. The contract has a completion date of December 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through...
This federal contract award is for the supply of Letrozole 2.5 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,519.85, was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This delivery order contract has a firm fixed price and is set to expire on August 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Letrozole 2.5 mg tablets. The $4,972.14 firm fixed-price delivery order has an ultimate completion date of October 17, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The federal contract award summarized is for the delivery of 4,567,096,577 tablets of the medication Letrozole 2.5 mg, with a total ceiling value of $3,877.59. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 31, 2025. The...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,048.80 firm-fixed-price contract is for the supply of 90-count bottles of the drug Letrozole 2.5 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,318.68 firm fixed-price delivery order is for the supply of 4,566,490,525 units of the medication Letrozole 2.5 mg tablets, with a completion date of November 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of 90 tablets of the medication Letrozole 2.5 mg to the Defense Logistics Agency (DLA). The $3,287.21 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 23, 2023, with a period of performance through October 24, 2023. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,672.24 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,110,874 Letrozole 2.5 mg tablets. The order has an ultimate completion date of October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the provision...